Clicks1
Love EWTN
Astrazeneca Announces New COVID-19 Vaccine, but Catholic Doctors Question the Ethics of Production This week, drug maker Astrazeneca announced its COVID-19 vaccine is "highly effective" in preventing…More
Astrazeneca Announces New COVID-19 Vaccine, but Catholic Doctors Question the Ethics of Production

This week, drug maker Astrazeneca announced its COVID-19 vaccine is "highly effective" in preventing the virus. It became the third major drug company this month to report successful late-stage data in testing. The vaccine showed a 70% efficacy rate, can be stored at warmer temperatures and would be cheaper than the Pfizer and Moderna vaccines. However, the National Catholic Bioethics Center says it was developed using aborted fetal cell lines, making it the least ethical option so far. The entire process of development of the vaccine, including the conception of vaccine, the development of the vaccine, and the testing of the vaccine, have involved abortion derived cell lines. Doctor Joseph Meaney, president of the National Catholic Bioethics Center, says fortunately the other vaccines reporting high success rates have not involved abortion derived cell line in the development or production phases. Correspondent Mark Irons reports. Don't miss out on the latest news and analysis from a Catholic perspective. Get EWTN News Nightly delivered to your email: ewtn.com/tv/shows/ewtn-news-nightly